Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 25 Mcg (0.025 Mg), 10 Tablets (10 X 1) Unit Dose Blisters Per Carton

Levothyroxine Sodium Tablets Recall Summary Major Pharmaceuticals is recalling 25 mcg Levothyroxine Sodium Tablets (10-tablet unit dose blisters, NDC 55154-3558-0) distributed nationwide because the tablets contain less active ingredient than labeled. This recall affects people in all U.S. states and Washington, DC who received this specific package.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Carton: 55154-3558-0; NDC Blister: 0904-6949-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/d6d301d4-f5a7-444d-9519-3ff1df270e6b